title: Optimistic assumptions in modelling studies have a substantial influence on the cost-effectiveness result.
authors.forename: P M J
authors.initials: PM
authors.lastname: Welsing
authors.forename: J L
authors.initials: JL
authors.lastname: Severens
authors.forename: R F J M
authors.initials: RF
authors.lastname: Laan
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics*; D018501:Antirheumatic Agents / Q000191:economics*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D000069285:Infliximab; D017059:Models, Econometric; D012107:Research Design
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab